EUVIMEDEUVIMED entdecken
Crossref

RBM15-mediated m6A methylation of Entpd1/CD39 regulates extracellular ATP hydrolysis and alleviates myocardial ischemia-reperfusion injury

Zhisheng Yan, Huihui Cao, Xiran Zhang, Yikang Wang, Qing Chang

International Immunopharmacology · 2025-09 · 162 · 115141

DOI: 10.1016/j.intimp.2025.115141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-09. Verfasst von Zhisheng Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266000, China. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Myocardial Reperfusion Injury, Apyrase, RNA-Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia-reperfusion (I/R) injury is a major cause of heart damage, linked to disrupted ATP metabolism and oxidative stress. While m6A RNA methylation regulates various cellular processes, its role in modulating I/R injury and ATP hydrolysis remains unclear. In this study, we demonstrate that both in vivo (rat I/R model) and in vitro (H/R-treated cardiomyocytes) models exhibit increased m6A modification levels during I/R injury. Among key m6A regulators, RBM15 is significantly upregulated in ischemic heart tissue. Functional assays reveal that RBM15 directly modulates the m6A methylation of Entpd1 (CD39), enhancing its expression and activity. Overexpression of RBM15 promotes ATP hydrolysis, resulting in increased adenosine production. These molecular changes collectively mitigated oxidative stress, reduced inflammation, and decreased apoptosis, resulting in improved cardiac function, smaller infarct sizes, and less cell death in the I/R model. These protective effects are reversed by CD39 inhibitor (sodium polyoxotungstate, POM-1), confirming the pivotal role of CD39 in this pathways. Mechanistically, RBM15 also activates the AMPK and AKT/ERK/GSK3β signaling pathway by increasing phosphorylation levels, further contributing to cardioprotection. In summary, RBM15-mediated m6A methylation enhances CD39 expression, facilitating extracellular ATP hydrolysis and exerting protective effects against myocardial I/R injury, highlighting its potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine TriphosphateMyocardial Reperfusion InjuryApyraseRNA-Binding ProteinsMyocytes, CardiacAntigens, CDAnimalsMethylationMaleHydrolysisRatsRats, Sprague-DawleyHumansAdenosineOxidative StressSignal TransductionDisease Models, AnimalApoptosis

Stichwörter der Autor:innen

ATP metabolismEntpd1/CD39Myocardial ischemia-reperfusion injuryRBM15m6A methylation

Substanzen

Adenosine TriphosphateApyraseCD39 antigenRNA-Binding ProteinsAntigens, CDAdenosineN-methyladenosine

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266000, China.
  • Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266000, China. Electronic address: changqing20671@qdu.edu.cn.

Zitieren

APA

Yan, Z., Cao, H., Zhang, X., Wang, Y., & Chang, Q. (2025). RBM15-mediated m6A methylation of Entpd1/CD39 regulates extracellular ATP hydrolysis and alleviates myocardial ischemia-reperfusion injury. International Immunopharmacology, 162, 115141. https://doi.org/10.1016/j.intimp.2025.115141

Vancouver

Yan Z, Cao H, Zhang X, Wang Y, Chang Q. RBM15-mediated m6A methylation of Entpd1/CD39 regulates extracellular ATP hydrolysis and alleviates myocardial ischemia-reperfusion injury. International Immunopharmacology. 2025;162:115141. doi:10.1016/j.intimp.2025.115141

BibTeX
@article{Yan2025,
  author = {Yan, Zhisheng and Cao, Huihui and Zhang, Xiran and Wang, Yikang and Chang, Qing},
  title = {RBM15-mediated m6A methylation of Entpd1/CD39 regulates extracellular ATP hydrolysis and alleviates myocardial ischemia-reperfusion injury},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {162},
  pages = {115141},
  doi = {10.1016/j.intimp.2025.115141}
}
Kostenlos starten →